Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06480760 · ClinicalTrials.gov registry record · Phase 1
Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
A Phase 1 study of Peripheral Arterial Disease, sponsored by Shahid Baba.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 144
- Enrollment target
- 3
- Study locations
NCT06480760 is a Phase 1 study of Peripheral Arterial Disease that is actively recruiting participants, run by Shahid Baba. The registered enrollment target is 144 participants, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT06480760, a Phase 1 study of Peripheral Arterial Disease, is actively recruiting participants, sponsored by Shahid Baba.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 144 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to determine whether carnosine (a food ingredient found in chicken and red meat) supplementation (2 g) for 6 months in participants with non-claudication and claudication peripheral arterial disease (PAD) improves walking ability. Previous studies with heart failure patients have shown that carnosine supplementation increases walking capacity in these patients.
Conditions Studied
Interventions
- DRUG Carnosine
Study Locations (3)
Kentucky
- University of Louisville School of Medicine, Department of Medicine, Division of Environmental Medicine - Louisville
- University Surgical Associates, 401 E. Chestnut St, Suite 710 - Louisville
- UofL Physicians - Vascular Surgery Associates, 201 Abraham Flexner Way, Suite 1004 - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2028-10-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06480760
The ClinicalTrials.gov registry entry for NCT06480760 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,204-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (97% lower). The listed sponsor is Shahid Baba, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Carnosine is the first listed.
NCT06480760 reports 3 study locations spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT06480760 about?
NCT06480760 is a clinical study titled "Effects of Carnosine In Patients With Peripheral Arterial Disease Patients". The purpose of this study is to determine whether carnosine (a food ingredient found in chicken and red meat) supplementation (2 g) for 6 months in participants with non-claudication and claudication peripheral arterial disease (PAD) improves walking ability. Previous studies with heart failure pati...
What is the current status of trial NCT06480760?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 144 participants. The study started on 2025-05-20. Estimated completion is 2028-10-01.
What conditions does trial NCT06480760 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
What interventions are being tested in trial NCT06480760?
The interventions under investigation include: Carnosine (DRUG).
Who is sponsoring clinical trial NCT06480760?
This trial is sponsored by Shahid Baba, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06480760 being conducted?
This trial has 3 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Carnosine for Peripheral Arterial Disease Patients
RECRUITING · Phase 1
-
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
ACTIVE NOT RECRUITING · Phase 1
-
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
COMPLETED · Phase 1
-
Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)
COMPLETED · Phase 1
-
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
COMPLETED · Phase 1
-
ALD-301 for Critical Limb Ischemia, Randomized Trial
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.